On March 16, 2021, Solid Biosciences joined PPMD for a webinar to provide a safety and efficacy update on the ongoing IGNITE DMD phase I/II clinical study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 1:09:01 Prosensa Update on Drisapersen (March 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:03:22 ACT DMD Update with PTC (February 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:05:32 Clinical Trials in Duchenne: A Behind the Scenes Look (December 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 1:15:13 Update on Natural History Data Study with Dr. Craig McDonald (November 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 56:44 Prosensa Update on Duchenne Program (August 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 51:35 MD STARnet (March 2013) 12 years ago Research & Clinical Trial Webinars,Webinars 1:09:49 Cardiac Webinar Series: Part 4 – Care for Adults Living with Duchenne (March 2013) 12 years ago Care Webinars,Webinars 1:32:45 Cardiac Webinar Series: Part 3 – The use of Ventricular Assist Devices in Duchenne (January 2013) 12 years ago Care Webinars,Webinars «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
